{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cidara Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"CDTX"},"Address":{"label":"Address","value":"6310 NANCY RIDGE DRIVE,SUITE 101, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 752-6170"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates."},"CompanyUrl":{"label":"Company Url","value":"https://www.cidara.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jeffrey L. Stein","title":"President, Chief Executive Officer & Director"},{"name":"Leslie Tari","title":"Chief Scientific Officer"},{"name":"Shane M. Ward","title":"COO, Chief Legal Officer & Secretary"},{"name":"Taylor Sandison","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}